Who Paid My Doc
Jose Araujo
Anatomic Pathology & Clinical Pathology Wauwatosa, WI Medical Doctor
NPI 1033282967 CMS profile 46984
11803 W North Ave, Wauwatosa, WI 53226
General payments
$902
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Jose Araujo of Wauwatosa, WI is reported in the CMS Open Payments database as having received $902 across 58 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 86th percentile of Anatomic Pathology & Clinical Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $51 | 1 | |
| 2021 | General | $162 | 8 | |
| 2020 | General | $420 | 28 | |
| 2019 | General | $268 | 21 |
Beside peers
- Jose Araujo
- Anatomic Pathology & Clinical Pathology median
- Middle half of Anatomic Pathology & Clinical Pathology
- National median
In program year 2025, general payments to Jose Araujo were reported at $0. Among 2,804 Anatomic Pathology & Clinical Pathology profiles paid that year, the median was $51 and the middle half received between $24 and $149.
Show as a table
| Year | Jose Araujo | Anatomic Pathology & Clinical Pathology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $268 | $65 | $22–$150 | $163 |
| 2020 | $420 | $44 | $19–$144 | $114 |
| 2021 | $162 | $42 | $19–$142 | $132 |
| 2022 | $51 | $54 | $20–$140 | $149 |
| 2023 | $0 | $60 | $23–$157 | $160 |
| 2024 | $0 | $51 | $23–$145 | $164 |
| 2025 | $0 | $51 | $24–$149 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 10 drugsPart D claims
428
Drug cost
$120,849
Branded share of claims
71%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Suboxone Buprenorphine Hcl/Naloxone Hcl | Brand | 75 | $54,677 | |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | Brand | 177 | $36,446 | |
| Ubrelvy Ubrogepant | Brand | 13 | $15,634 | |
| Zubsolv Buprenorphine Hcl/Naloxone Hcl | Brand | 12 | $10,846 | |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | Brand | 27 | $1,205 | |
| Methylphenidate Hcl | Generic | 29 | $1,175 | |
| Gabapentin | Generic | 61 | $553 | |
| Esomeprazole Magnesium | Generic | 12 | $192 | |
| Quetiapine Fumarate | Generic | 11 | $72 | |
| Escitalopram Oxalate | Generic | 11 | $48 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 205 Part D prescribers listed as Pathology; they describe a distribution and say nothing about conduct.
Records
58 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Anatomic Pathology & Clinical Pathology in Wisconsin
Practitioners in the same specialty and state, ranked by reported value.
All Anatomic Pathology & Clinical Pathology
Everyone recorded under this specialty, nationwide.
Doctors in Wisconsin
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.